Koers Pure Global Cannabis Inc Toronto S.E.
Aandelen
RSL
CA7806782073
Farmaceutische producten
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 24,16 mln. 33,28 mln. 22,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 0 | Nettowinst (verlies) 2018 | -23 mln. -31,69 mln. -21,58 mln. | EV/omzet 2017 * | - |
Nettoschuld 2017 | 211K 291K 198K | Nettoschuld 2018 | 4,49 mln. 6,19 mln. 4,21 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-0,72
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 83,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 30-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 01-07-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,01 mld. | |
-18,38% | 4,4 mld. | |
-9,17% | 3,17 mld. | |
+3,98% | 3,07 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,88 mld. | |
-4,82% | 1,73 mld. | |
-1,24% | 1,65 mld. | |
-8,96% | 1,58 mld. |